COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,435 Articles (22,835 medRxiv, 8,600 bioRxiv)

Most recent first Previous |  Page 2578: Articles 25771-25780  | Next

4S-DT: Self Supervised Super Sample Decomposition for Transfer learning with application to COVID-19 detection
Abbas, A., Abdelsamea, M., Gaber, M.
10.1101/2020.06.22.20137547 — Posted: 2020-06-23
Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web-based survey of 780,961 participants
Alam, M. R., Kabir, M. R., Reza, S.
10.1101/2020.06.22.20137422 — Posted: 2020-06-23
Factors associated with self-reported anxiety, depression, and general health during the UK lockdown; a cross-sectional survey
Smith, L. E., Amlot, R., Lambert, H., Oliver, I., Robin, C., Yardley, L., Rubin, G. J.
10.1101/2020.06.23.20137901 — Posted: 2020-06-23
A primary care approach to the COVID-19 pandemic: clinical features and natural history of 2,073 suspected cases in the Corona Sao Caetano programme, Sao Paulo, Brazil
Leal, F. E., Mendes-Correa, M. C., Buss, L. F., Costa, S. F., Bizario, J. C., Souza, S. R., Thomaz, O., Tozetto-Mendoza, T. R., Villas-Boas, L. S., Silva, L. C., Grespan, R. M., Capuani, L., Buccheri, R., Domingues, H., Alexander, N. D., Mayaud, P., Sabino, E. C.
10.1101/2020.06.23.20138081 — Posted: 2020-06-23
On Dynamical Analysis of the Data-DrivenSIR model (COVID-19 Outbreak in Indonesia)
Sulaiman, A.
10.1101/2020.06.22.20137810 — Posted: 2020-06-23
Age-structured non-pharmaceutical interventions for optimal control of COVID-19 epidemic
Richard, Q., Alizon, S., Choisy, M., Sofonea, M. T., Djidjou-Demasse, R.
10.1101/2020.06.23.20138099 — Posted: 2020-06-23
Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay
Valdivia, A., Torres, I., Huntley, D., Alcaraz, M. J., Albert, E., Colomina, J., Ferrer, J., Carratala, A., Navarro, D.
10.1101/2020.06.23.20138016 — Posted: 2020-06-23
The impact of COVID-19 non-pharmaceutical interventions on the future dynamics of endemic infections
Baker, R. E., Park, S. W., Yang, W., Vecchi, G. A., Metcalf, C. J. E., Grenfell, B. T.
10.1101/2020.06.22.20137588 — Posted: 2020-06-23
SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers
Rudberg, A.-S., Havervall, S., Manberg, A., Jernbom Falk, A., Aguilera, K., Ng, H., Gabrielsson, L., Salomonsson, A.-C., Hanke, L., Murell, B., McInerney, G., Olofsson, J., Andersson, E., Hellstrom, C., Bayati, S., Bergstrom, S., Pin, E., Sjoberg, R., Tegel, H., Hedhammar, M., Phillipson, M., Nilsson, P., Hober, S., Thalin, C.
10.1101/2020.06.22.20137646 — Posted: 2020-06-23 Discussion: Offsite
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19
Psichogiou, M., Karabinis, A., Pavlopoulou, I. D., Basoulis, D., Petsios, K., Roussos, S., Patrikaki, M., Jahaj, E., Protopapas, K., Leontis, K., Rapti, V., Kotanidou, A., Antoniadou, A., Poulakou, G., Paraskevis, D., Sypsa, V., Hatzakis, A.
10.1101/2020.06.23.20137620 — Posted: 2020-06-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).